… we have focused on commonly used coagulation assays and included several different
reagents in order to get a picture of the differences in sensitivities within each assay group. An in …

… Apixaban is an oral direct factor Xa inhibitor developed for the prophylaxis and treatment
of … on common coagulation reagents and assays constitute clinically valuable information. …

… The responsiveness of the INR to different drug concentrations differs with assay reagent
and with the type of direct thrombin inhibitor. Although all direct thrombin inhibitors prolong the …

… assay interferences. The effect of these conventional and new anticoagulant agents on specialty
coagulation assays … to the APTT because it provides a direct measure of heparin activity. …

… Laboratory assays measuring dynamic clotting parameters … This review highlights the role
of specialized coagulation assays in … Direct factor replacement may therefore be favourable to …

… of dabigatran on common coagulation assays not only in … on coagulation assays (17, 18),
we believe the coagulation laboratories need a more thorough knowledge, ie more coagulation …

… concentration of DOAC with these routine coagulation assays and that significant anticoagulant
effect may still be present despite normal or near normal results for these routine assays. …

… coagulation monitoring with rivaroxaban – an oral, direct factor Xa inhibitor – a haemostasis
assay … This study aimed to find assays, among those commercially available, to measure …

… Factor activity assays are most commonly … of direct-acting oral anticoagulants (DOACs): [1]
The oral direct thrombin inhibitors (DTIs) such as dabigatran; and [2] The oral direct factor Xa …

… We evaluated the significance of effects of DTI on different coagulation assays in different
concentrations with the Friedman paired signed rank test using SPSS software (version 19, …